Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15 mg/0.025 mg, 28-count tablets per dispenser (NDC 52544-959-28), packaged in 3-count Tablet Dispensers per carton (NDC 52544-959-31), Rx only Manufactured by: Watson Laboratories, Inc., Corona, CA 92880; Distributed by: Watson Pharma, Inc., Corona, CA 92880.
Published August 8, 2012 · Recall initiated: June 5, 2012
Summary
FDA records drug Class III recall D-1436-2012, published August 8, 2012 and initiated June 5, 2012. Recalling firm: Watson Laboratories Inc; Status: Terminated; Reported quantity: 18,938 cartons; Lot: Lot #s: 412572A, 412572B, Exp 11/12. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Impurities/Degradation Products: High Out-of-specification results were obtained for both known and unknown impurities.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Watson Laboratories Inc
- Distributor
- Nationwide.
- Lot
- Lot #s: 412572A, 412572B, Exp 11/12
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAHydrocodone Bitartrate and Acetaminophen Tablets USP, CIII, 10 mg/ 660 mg, 100 count bottles, Rx only.February 5, 2014
- FDACarisoprodol Tablets, USP, CIV, 350 mg, 500 count bottle, Rx only. Manufactured by Watson Pharma Private Ltd,January 15, 2014
- FDANext Choice" One Dose Emergency Contraceptive (Levonorgestrel Tablet), 1.5 mg, 1 Tablet/Blister Card (NDCOctober 16, 2013
- FDAOxycodone and Acetaminophen Tablets, USP 10 mg/650 mg, CII, 100 Count Bottles, Rx Only, Manufactured by:October 9, 2013
- FDADr. Reddy's Ciprofloxacin Tablets, USP 500 mg*, 500 Tablets, Rx only, Mfd. By: Dr. Reddy's LaboratoriesAugust 8, 2012
- FDAFosphenytoin Sodium Injection, USP, 100 mg PE per 2 mL (50 mg PE per mL), 2 mL Single Dose Vial, packaged inAugust 8, 2012
Questions about this recall
Was Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15 mg/0.025 mg, 28-count tablets per dispenser (NDC 52544-959-28), packaged in 3-count Tablet Dispensers per carton (NDC 52544-959-31), Rx only Manufactured by: Watson Laboratories, Inc., Corona, CA 92880; Distributed by: Watson Pharma, Inc., Corona, CA 92880. recalled?
Yes. FDA published recall D-1436-2012 on August 8, 2012. Reported hazard: Impurities/Degradation Products: High Out-of-specification results were obtained for both known and unknown impurities.
What should I do if I have this product?
Voluntary: Firm initiated · Letter